14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 30th Aug 2023 TCRR stock ended at $1.48. During the day the stock fluctuated 0% from a day low at $1.48 to a day high of $1.48.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical TCR2 Therapeutics Inc. prices

Date Open High Low Close Volume
Mar 02, 2023 $1.29 $1.30 $1.19 $1.20 103 846
Mar 01, 2023 $1.20 $1.39 $1.17 $1.28 202 588
Feb 28, 2023 $1.20 $1.28 $1.14 $1.25 234 567
Feb 27, 2023 $1.14 $1.19 $1.08 $1.17 67 773
Feb 24, 2023 $1.17 $1.17 $1.07 $1.10 156 437
Feb 23, 2023 $1.12 $1.20 $1.10 $1.19 249 234
Feb 22, 2023 $1.21 $1.28 $1.11 $1.13 173 800
Feb 21, 2023 $1.22 $1.24 $1.17 $1.19 97 322
Feb 17, 2023 $1.23 $1.24 $1.21 $1.23 101 864
Feb 16, 2023 $1.24 $1.28 $1.22 $1.25 65 633
Feb 15, 2023 $1.31 $1.31 $1.22 $1.27 121 587
Feb 14, 2023 $1.26 $1.32 $1.27 $1.30 48 728
Feb 13, 2023 $1.28 $1.32 $1.25 $1.28 89 491
Feb 10, 2023 $1.33 $1.33 $1.27 $1.28 55 809
Feb 09, 2023 $1.27 $1.47 $1.26 $1.32 90 047
Feb 08, 2023 $1.36 $1.38 $1.26 $1.28 190 008
Feb 07, 2023 $1.40 $1.47 $1.32 $1.38 112 066
Feb 06, 2023 $1.44 $1.46 $1.41 $1.41 69 434
Feb 03, 2023 $1.40 $1.45 $1.38 $1.44 84 772
Feb 02, 2023 $1.43 $1.48 $1.35 $1.38 240 744
Feb 01, 2023 $1.49 $1.49 $1.40 $1.40 135 538
Jan 31, 2023 $1.41 $1.52 $1.41 $1.45 147 072
Jan 30, 2023 $1.48 $1.50 $1.39 $1.40 114 442
Jan 27, 2023 $1.42 $1.48 $1.37 $1.48 174 971
Jan 26, 2023 $1.38 $1.40 $1.35 $1.38 80 207
Click to get the best stock tips daily for free!

About TCR2 Therapeutics Inc.

TCR2 Therapeutics. TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal... TCRR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT